clasto-lactacystin beta-lactone has been researched along with salinosporamide b in 1 studies
| Studies (clasto-lactacystin beta-lactone) | Trials (clasto-lactacystin beta-lactone) | Recent Studies (post-2010) (clasto-lactacystin beta-lactone) | Studies (salinosporamide b) | Trials (salinosporamide b) | Recent Studies (post-2010) (salinosporamide b) |
|---|---|---|---|---|---|
| 85 | 0 | 15 | 9 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, TH; Deyanat-Yazdi, G; Fenical, WF; Jensen, PR; Lam, KS; Macherla, VR; Mai, B; Manam, RR; Mitchell, SS; Neuteboom, ST; Nicholson, B; Palladino, MA; Potts, BC; Reed, KA | 1 |
1 other study(ies) available for clasto-lactacystin beta-lactone and salinosporamide b
| Article | Year |
|---|---|
Structure-activity relationship studies of salinosporamide A (NPI-0052), a novel marine derived proteasome inhibitor.
Topics: Actinobacteria; Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Humans; Lactones; Marine Biology; NF-kappa B; Proteasome Inhibitors; Pyrroles; Rabbits; Stereoisomerism; Structure-Activity Relationship | 2005 |